Developed domain profile
UMP.com
Biotechnology International, published online by Universal Medical Press at UMP.COM
Research summary
The profile at a glance.
The classification and value describe the domain asset itself. They do not value or imply availability of any operating business.
Classification confidenceHighAcquisition-signal confidenceLimitedValue confidenceDeveloping
Why TLL classifies it this way
UMP.COM is identified as the current public web identity of Universal Medical Press, Inc.. This current-use classification is separate from TLL's domain-only valuation.
Recorded expansion: Universal Medical Press
Read the research methodology →Current digital identity
Website Capture
This is how Universal Medical Press, Inc. is currently represented at UMP.COM.
Identity and market context
UMP.COM Domain Overview
Universal Medical Press, Inc. publishes Biotechnology International, a biotechnology publication focused on biannual coverage of recent advances in the field. The publication presents biotechnology developments through a recurring editorial format, with the site also offering an organization-specific contact address for further information. UMP.COM serves as Universal Medical Press’s primary online identity, connecting the publisher’s verified initials with its publication presence. The homepage carries a 1997–2025 copyright notice and positions the publication around current and emerging biotechnology topics.
Identity details
- Organization
- Universal Medical Press, Inc.
- Identity role
- Primary identity
- Industry
- Technology
- Source
- Open current-use source ↗
Estimated UMP.COM domain value
$150,000–$349,999UMP carries a concise, familiar abbreviation for “umpire,” giving it more intrinsic memorability than most arbitrary strings. Its pronunciation is clear and its consonant-vowel balance is serviceable, while the ending P adds visual firmness. Generic technical expansions broaden possible use, although the sports-related reading can dominate interpretation and somewhat narrows neutrality across categories.
Intrinsic score47/100Marketability gradeEModel statusDirectional estimate
Directional estimate of the domain asset, separate from the current brand or business. Existing trademark associations may limit practical transferability.Related opportunities
Similar Domains With Acquisition Signals
UTP.COMPremium↗UPP.COMPremium↗UXP.COMHigh Premium↗UKP.COMMarketable↗UWP.COMMarketable↗UGP.COMFoundational↗
These domains are privately held and may require direct outreach or brokerage to acquire.
Analyst note
UMP is a compact, three-letter initialism that directly condenses Universal Medical Press, giving UMP.COM a clear structural link to the organization’s verified name. Its three uppercase characters form a clean visual block, while the letters are easy to say individually—“U-M-P”—and quick to recognize, type, and retain. The sequence carries no competing dictionary meaning, keeping the association focused on the initials. The .com ending frames it as a straightforward organizational web address. UMP.COM identifies the publisher behind Biotechnology International.Asset-only research estimate · 2026
Comparable identities
Comparable Developed Identities
DomainAgents
Acquisition partnerResearch the Domain.
Research the Domain.
Contact the Owner.
DomainAgents has facilitated more than 300,000 domain negotiations since 2012.
TLL is free and has no subscription. Owner outreach costs $19.95. When a buyer-initiated acquisition completes, DomainAgents charges a 10% buyer success fee, reduced to 7.5% above $25,000. Public TLL estimates use public signals; private negotiation data is not used.
Explore DomainAgents ↗Keep exploring
Explore Another 3-Letter .com
Search any three-letter combination to see its profile and estimated value.